Pharming Group (PHAR) Balance Sheet: Assets & Liabilities

Pharming Group (PHAR) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Pharming Group reported total assets of EUR 499.81M and total liabilities of EUR 222.79M. Shareholders' equity was EUR 277.02M, up 21.0% from EUR 228.91M a year earlier. Total debt stood at EUR 115.78M against EUR 179.81M in cash and short-term investments, a net cash position of EUR 64.03M. That puts debt-to-equity at 0.42, compared with 0.51 a year earlier.

Pharming Group Balance Sheet Analysis

Values in millions EUR

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Pharming Group N.V. (PHAR) - Annual data in millions EUR
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	146.02	56.89	61.74	207.34	191.92	205.16	74.35	80.31	70.37
Short-Term Investments	33.79	116.96	151.68	0.00	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	179.81	173.85	213.42	207.34	191.92	205.16	74.35	80.31	70.37
Accounts Receivable	54.69	51.95	42.62	27.62	18.08	31.88	28.86	15.34	8.90
Inventory	64.88	57.70	56.76	42.33	27.31	21.16	16.22	17.32	22.00
Other Current Assets	0.00	4.82	3.54	0.21	2.97	4.02	0.00	2.48	4.61
Total Current Assets	299.38	288.32	316.34	277.50	249.44	263.21	119.44	115.44	105.87
Non-Current Assets
Property, Plant & Equipment (Net)	23.96	24.12	33.47	39.15	33.17	21.65	16.30	9.61	9.88
Long-Term Investments	9.87	4.38	10.40	9.73	7.20	7.12	6.18	2.29	2.75
Goodwill	135.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Intangible Assets	0.00	63.21	71.27	74.87	83.83	88.63	79.40	59.98	67.94
Other Non-Current Assets	0.09	2.52	1.62	24.30	0.81	0.51	2.54	-12.97	1.60
Total Non-Current Assets	200.43	125.86	146.51	148.30	147.87	127.08	136.48	99.04	93.50
Total Assets	499.81	414.18	462.85	425.80	397.32	418.45	255.92	214.48	199.38
Current Liabilities
Accounts Payable	105.87	10.46	16.02	54.47	7.60	13.47	40.65	7.60	11.31
Short-Term Debt	8.71	7.45	5.44	1.77	1.88	2.04	53.31	40.61	22.66
Current Portion of Long-Term Debt	5.34	4.25	1.82	1.77	1.88	2.04	-	-	-
Accrued Liabilities	91.31	53.22	50.27	43.61	33.34	33.40	-	-	-
Deferred Revenue	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.92	0.96
Other Current Liabilities	1.22	55.11	50.27	43.61	37.83	25.36	20.51	31.03	35.28
Total Current Liabilities	115.79	76.42	77.97	59.70	46.77	76.85	114.25	82.60	70.22
Non-Current Liabilities
Long-Term Debt	107.07	108.85	166.11	131.62	139.01	149.73	4.89	42.82	71.44
Deferred Tax Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.10	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.17	0.21	19.38	32.06	33.40
Total Non-Current Liabilities	107.07	108.85	166.11	161.46	157.63	129.48	24.27	70.13	106.61
Total Liabilities	222.79	185.27	244.07	221.16	204.40	235.02	138.53	152.73	176.82
Stockholders' Equity
Common Stock	8.01	8.04	7.67	7.51	7.43	7.31	7.23	6.22	5.79
Retained Earnings	-272.90	-285.27	-265.26	-256.43	-273.17	-271.01	-340.72	-331.99	-353.50
Accumulated Other Comprehensive Income	0.00	-0.21	-2.06	-8.74	3.40	0.00	8.93	1.88	-1.13
Additional Paid-in Capital	541.91	488.99	478.43	462.30	455.25	366.02	441.95	446.07	434.41
Shares Outstanding	701.68	680.31	671.07	656.35	648.75	-	-	-	-
Total Stockholders' Equity	277.02	228.91	218.78	204.64	192.92	183.44	117.39	61.75	16.11
Total Liabilities & Equity	499.81	399.99	462.85	425.80	397.32	342.55	255.92	245.45	199.38

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Pharming Group Balance Sheet

How much debt does Pharming Group have?

Pharming Group had total debt of EUR 115.78M as of Dec 31, 2025, against EUR 179.81M in cash and short-term investments. Its debt-to-equity ratio was 0.42. Total debt was EUR 116.30M a year earlier.

What are Pharming Group's total assets?

Pharming Group reported total assets of EUR 499.81M as of Dec 31, 2025, up 20.7% from EUR 414.18M a year earlier. Total liabilities were EUR 222.79M.

What is Pharming Group's shareholders' equity?

Pharming Group's shareholders' equity was EUR 277.02M as of Dec 31, 2025, or about EUR 0.39 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition